The capsule endoscopy market has seen considerable growth due to a variety of factors.
• In recent years, the market size for capsule endoscopy has experienced significant expansion. The market, which is valued at $0.69 billion in 2024, is predicted to increase to $0.76 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.14%.
Factors contributing to this growth during the historic period include a heightened prevalence of gastrointestinal conditions, a rising preference for non-invasive tests, an aging population, increased education about gastrointestinal disorders, and a surge in health consciousness.
The capsule endoscopy market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of capsule endoscopy is projected to witness rapid expansion in the coming years. The market is anticipated to reach a value of $1.15 billion in 2029, representing a compound annual growth rate (CAGR) of 10.88%.
This significant upsurge during the forecast period can be attributed to factors such as the emergence of telemedicine and mobile health solutions, increasing acceptance of minimally invasive medical technologies, a rising preference for outpatient procedures, an escalating demand for early diagnosis, and the growing need for patient-friendly diagnostic equipment. The major trends expected during the forecast period encompass technological progress, innovations in capsule design, advancements of minimally invasive procedures, integration with artificial intelligence, and discoveries in biodegradable capsules.
The growing incidence of gastrointestinal diseases is anticipated to propel the expansion of the capsule endoscopy market. This includes conditions affecting the digestive system such as indigestion, inflammatory bowel disease (IBD), and gastrointestinal cancers. This rise can be linked to different factors like improper diet, stress, inactive lifestyles, overuse of antibiotics, an aging demographic, environmental pollutants, resistance to antibiotics, and changes in the gut microbiome. Capsule endoscopy offers a non-intrusive, comprehensive examination of the gastrointestinal tract, facilitating early detection and better management of conditions like Crohn’s disease, ulcers, and gastrointestinal bleeding. For instance, the IBD Registry, a UK based non-profit organization, reported in December 2023 that individuals diagnosed with Inflammatory Bowel Disease (IBD) exceeded 5,300; an increase of over 3,000 members compared to 2022. Therefore, the growing incidence of gastrointestinal diseases is fueling the expansion of the capsule endoscopy market.
The capsule endoscopy market covered in this report is segmented –
1) By Product: Capsule Endoscopes, Systems
2) By Application: Obscure Gastrointestinal Bleeding (OGIB), Crohns Disease, Small Intestine Tumor, Other Applications
3) By End User: Hospitals, Diagnostic Laboratories, Specialty Clinics
Subsegments:
1) By Small Bowel Capsule Endoscopes: Small Bowel Capsule Endoscopes, Esophageal Capsule Endoscopes, Colon Capsule Endoscopes, Specialty Capsule Endoscopes
2) By Systems: Workstations And Recorders, Software Platforms, Accessories
Leading businesses in the capsule endoscopy market are concentrating their efforts on creating trailblazing technologies, like magnetically controlled capsule endoscopy systems, to improve diagnostic precision, increase patient comfort, and broaden the usability of gastrointestinal imaging. Magnet-controlled capsule endoscopy systems are a revolutionary diagnostic system that leverages external magnetic fields to navigate a camera capsule that's easily swallowable for in-depth, non-intrusive imaging of the gastrointestinal tract. An example of this was when AnX Robotica Corporation, a US-based manufacturer of equipment, unveiled the NaviCam Small Bowel System in February 2023 to refine the visualisation of the small bowel, which is vital for identifying various gastrointestinal conditions. This advanced system presents a magnetically controlled capsule packed with high resolution imaging capabilities that enable live tracking and visualisation of the small bowel. The system also encompasses AI-enabled analytics that allow the swift and accurate identification of irregularities, thus enhancing the diagnostic procedure. The NaviCam Small Bowel System's non-invasive approach and cutting-edge technology sets a new industry standard for efficiency and effectiveness in gastrointestinal healthcare practices.
Major companies operating in the capsule endoscopy market are include:
• Medtronic plc
• Fujifilm Holdings Corporation
• Boston Scientific Corporation
• Olympus Corporation
• STERIS plc
• Given Imaging Ltd.
• Check-Cap Ltd.
• Micro-Tech Endoscopy
• CapsoVision Inc.
• Stratis Medical Inc.
• IntroMedic Co. Ltd.
• RF System Lab Co. Ltd.
• Ankon Technologies Co. Ltd.
• AnX Robotica Corporation
• AccuRead Endoscopy Inc.
• Chongqing Jinshan Science & Technology Group Co. Ltd.
• BioCam
• SynMed Medical Technology Co. Ltd.
• Anhan Technology Co. Ltd.
• Shengxian Minimal Invasive Inc.
North America was the largest region in the capsule endoscopy market in 2024. The regions covered in the capsule endoscopy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.